QURE uniQure NV

  1. Stocks
  2. Healthcare
  3. NASDAQ: QURE

Price (delayed)

$4.705

Market cap

$225.08M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$6.47

Enterprise value

$516.37M

uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline ...

Highlights
The quick ratio is up by 41% year-on-year but it is down by 12% since the previous quarter
The net income has dropped by 143% year-on-year and by 35% since the previous quarter
The company's EPS has shrunk by 139% YoY and by 35% QoQ
Sector: Healthcare
Industry: Biotechnology
Peers: AMGN SGMO BLUE RNA

Key stats

What are the main financial stats of QURE
Market
Shares outstanding
47.84M
Market cap
$225.08M
Enterprise value
$516.37M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.08
Price to sales (P/S)
14.16
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
32.59
Earnings
Revenue
$15.84M
EBIT
-$265M
EBITDA
-$253.1M
Free cash flow
-$153.08M
Per share
EPS
-$6.47
Free cash flow per share
-$3.21
Book value per share
$4.34
Revenue per share
$0.33
TBVPS
$15.62
Balance sheet
Total assets
$831.69M
Total liabilities
$624.02M
Debt
$532.65M
Equity
$207.67M
Working capital
$578.18M
Liquidity
Debt to equity
2.56
Current ratio
8.85
Quick ratio
8.44
Net debt/EBITDA
-1.15
Margins
EBITDA margin
-1,597.6%
Gross margin
14%
Net margin
-1,947.1%
Operating margin
-1,785.5%
Efficiency
Return on assets
-37.7%
Return on equity
-99.3%
Return on invested capital
-32.8%
Return on capital employed
-35%
Return on sales
-1,672.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

QURE stock price

How has the uniQure stock price performed over time
Intraday
0.75%
1 week
-6.46%
1 month
-5.33%
1 year
-75.63%
YTD
-30.5%
QTD
-9.52%

Financial performance

How have uniQure's revenue and profit performed over time
Revenue
$15.84M
Gross profit
$2.22M
Operating income
-$282.87M
Net income
-$308.48M
Gross margin
14%
Net margin
-1,947.1%
The net income has dropped by 143% year-on-year and by 35% since the previous quarter
The gross profit has plunged by 98% from the previous quarter and by 98% YoY
QURE's operating income has shrunk by 98% YoY and by 45% QoQ
The company's revenue has shrunk by 86% QoQ and by 85% YoY

Growth

What is uniQure's growth rate over time

Valuation

What is uniQure stock price valuation
P/E
N/A
P/B
1.08
P/S
14.16
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
32.59
The company's EPS has shrunk by 139% YoY and by 35% QoQ
QURE's P/B is 78% below its 5-year quarterly average of 4.8 and 33% below its last 4 quarters average of 1.6
The equity has shrunk by 56% YoY and by 23% QoQ
The P/S is 88% lower than the 5-year quarterly average of 113.4 but 53% higher than the last 4 quarters average of 9.2
The company's revenue has shrunk by 86% QoQ and by 85% YoY

Efficiency

How efficient is uniQure business performance
The ROA has plunged by 108% YoY and by 30% from the previous quarter
The return on equity has dropped by 64% since the previous quarter
The return on invested capital has increased by 23% year-on-year but it has declined by 12% since the previous quarter

Dividends

What is QURE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for QURE.

Financial health

How did uniQure financials performed over time
QURE's total assets is 33% greater than its total liabilities
The total liabilities has soared by 173% YoY and by 3.5% from the previous quarter
The current ratio has grown by 41% YoY but it has contracted by 12% from the previous quarter
The debt is 156% higher than the equity
The equity has shrunk by 56% YoY and by 23% QoQ
The debt to equity is up by 32% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.